CPH 0.00% 0.9¢ creso pharma limited

Ann: Half Yearly Report and Accounts, page-5

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 4,821 Posts.
    lightbulb Created with Sketch. 177
    for anyone who is interested
    PCLO Financial Highlights – Q2 – 2019
    Operating Results
    All comparisons below are to the quarter ended June 30, 2018, unless otherwise noted
    Total operating expenses of $8.8 million as compared to $3.1 million
    Net loss of $10.7 million as compared to $3.8 million
    Balance Sheet for PCLO (canada)
    All comparisons below are to December 31, 2018, unless otherwise noted
    Cash and short-term investments of $33.2 million as compared to $45.9 million
    Total assets of $58.6 million as compared to $66.3 million
    Total liabilities of $6.5 million as compared to $3.0 million
    Last edited by rae915: 29/08/19
 
watchlist Created with Sketch. Add CPH (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.